Details

NameSymbolSector
MARKSANS PHARMA LTD.MARKSANSPharmaceuticals
Open
308.1
High
313.5
Low
306
Close
311
Volume
767998
Exchange
nse
Time
16-Oct-2026

Outlook

Score:  

4.5

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Marksans Pharma is  
None
Estimated Stoploss of Marksans Pharma is ₹  
306
Marksans Pharma has a  
Bullishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Marksans Pharma is  
Unpredictableℹ
. 

Trend

Marksans Pharma is in  
Sideways trendℹ
. 
Price of Marksans Pharma is  
Downℹ
 by  

0.52

%. 
Target
Buy @ 

235.47

Sell @ 

362.05

Current @ 

311

Volume

The trade volumes of Marksans Pharma have become  
Deficientℹ
The volume trend for Marksans Pharma is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Marksans Pharma is  

Down

 by  

76.1

% 

Valuation

The current market price of Marksans Pharma is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 3239cr and total assets worth ₹ 3239cr, the balance sheet of Marksans Pharma is:  
Balancedℹ
. 
Cashflow
Marksans Pharma has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 92cr

. It is  
Upℹ
 by  

360

%. 

(*Mar 2025)

64.38% i.e. ₹ 206cr earned in operatingℹ
15.31% i.e. ₹ 49cr spent in investingℹ
20.31% i.e. ₹ 65cr spent in financingℹ
0% in otherℹ
Marksans Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 20cr

. It is  
Downℹ
 by  

88.64

%. 

(*Mar 2024)

52.51% i.e. ₹ 230cr earned in operatingℹ
31.96% i.e. ₹ 140cr spent in investingℹ
15.53% i.e. ₹ 68cr spent in financingℹ
0% in otherℹ
Income
The income of Marksans Pharma is  

₹ 741cr

 and  

Profit

 is :  

₹ 99cr

(*Sep 2025)

Marksans Pharma Profit is up by:  

70.69

% and Income is Up by:  

18.56

% 

(*Sep 2025)

The income of Marksans Pharma is  

₹ 625cr

 and  

Profit

 is :  

₹ 58cr

(*Jun 2025)

Marksans Pharma Profit is down by:  

35.56

% and Income is Down by:  

13.67

% 

(*Jun 2025)

The income of Marksans Pharma is  

₹ 724cr

 and  

Profit

 is :  

₹ 90cr

(*Mar 2025)

Marksans Pharma Profit is down by:  

14.29

% and Income is Up by:  

2.12

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.